Oregon Health and Science University

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Medications for the Treatment of Dysthymic Disorder and Double Depression

Phase 4
Completed
Conditions
First Posted Date
2005-10-06
Last Posted Date
2019-07-29
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
40
Registration Number
NCT00234312
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health Sciences University, Portland, Oregon, United States

Effectiveness of Supplemental Calcium in Preventing Postpartum Depression

Phase 4
Completed
Conditions
First Posted Date
2005-09-28
Last Posted Date
2014-03-20
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
238
Registration Number
NCT00228033
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health & Science University, Portland, Oregon, United States

Efalizumab for Moderate to Severe Atopic Dermatitis

Phase 1
Completed
Conditions
Interventions
First Posted Date
2005-09-26
Last Posted Date
2020-01-03
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
10
Registration Number
NCT00226057

Pilot Trial of a Behavioral Treatment for Epilepsy

First Posted Date
2005-09-21
Last Posted Date
2019-08-01
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
8
Registration Number
NCT00212745
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health and Science University, Portland, Oregon, United States

A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood

First Posted Date
2005-09-21
Last Posted Date
2011-10-26
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
17
Registration Number
NCT00212758
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Stanford University Medical Center, Stanford, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Texas Children's Hospital, Houston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of California in Los Angeles (UCLA), Los Angeles, California, United States

and more 5 locations

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

First Posted Date
2005-08-18
Last Posted Date
2019-04-24
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
79
Registration Number
NCT00131469
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Kennedy Krieger Institute, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health & Science University, Portland, Oregon, United States

๐Ÿ‡บ๐Ÿ‡ธ

Baylor College of Medicine, Department of Molecular and Human Gentics, Houston, Texas, United States

Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic Syndrome

First Posted Date
2005-08-12
Last Posted Date
2014-10-29
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
79
Registration Number
NCT00129792
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health and Science University General Clinical Research Center, Portland, Oregon, United States

Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis

First Posted Date
2005-07-22
Last Posted Date
2017-06-08
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
39
Registration Number
NCT00122954
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Oregon Health and Science University, Portland, Oregon, United States

4% Intrauterine Lidocaine Infusion for Pain Management in First Trimester Abortions

Not Applicable
Completed
Conditions
First Posted Date
2005-07-21
Last Posted Date
2005-07-21
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
80
Registration Number
NCT00121329
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Planned Parenthood of the Columbia Willamette, Portland, Oregon, United States

Continuous Oral Contraceptives (COCs): Are Bleeding Patterns Dependent on the Hormones Given?

Not Applicable
Completed
Conditions
First Posted Date
2005-07-19
Last Posted Date
2005-07-19
Lead Sponsor
Oregon Health and Science University
Target Recruit Count
160
Registration Number
NCT00120913
Locations
๐Ÿ‡บ๐Ÿ‡ธ

OHSU, Portland, Oregon, United States

ยฉ Copyright 2024. All Rights Reserved by MedPath